These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35918708)

  • 1. Pathophysiology of mesangial expansion in diabetic nephropathy: mesangial structure, glomerular biomechanics, and biochemical signaling and regulation.
    Thomas HY; Ford Versypt AN
    J Biol Eng; 2022 Aug; 16(1):19. PubMed ID: 35918708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases.
    Suzuki D; Miyata T; Nangaku M; Takano H; Saotome N; Toyoda M; Mori Y; Zhang SY; Inagi R; Endoh M; Kurokawa K; Sakai H
    J Am Soc Nephrol; 1999 Dec; 10(12):2606-13. PubMed ID: 10589701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the BMP4/Smad1 signaling pathway in mesangial cell proliferation: A possible mechanism of diabetic nephropathy.
    Chen C; Lin J; Li L; Zhu T; Gao L; Wu W; Liu Q; Ou S
    Life Sci; 2019 Mar; 220():106-116. PubMed ID: 30708099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mesangial expansion in the pathogenesis of diabetic nephropathy.
    Dalla Vestra M; Saller A; Mauer M; Fioretto P
    J Nephrol; 2001; 14 Suppl 4():S51-7. PubMed ID: 11798146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic nephropathy. Mechanisms of mesangial matrix expansion.
    Abrass CK
    West J Med; 1995 Apr; 162(4):318-21. PubMed ID: 7747496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy.
    Tung CW; Hsu YC; Shih YH; Chang PJ; Lin CL
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():32-37. PubMed ID: 30298646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of type VIII collagen in mice ameliorates diabetic nephropathy.
    Hopfer U; Hopfer H; Meyer-Schwesinger C; Loeffler I; Fukai N; Olsen BR; Stahl RA; Wolf G
    Diabetes; 2009 Jul; 58(7):1672-81. PubMed ID: 19401424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients.
    Steffes MW; Osterby R; Chavers B; Mauer SM
    Diabetes; 1989 Sep; 38(9):1077-81. PubMed ID: 2670639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Morphogenetic Protein 4 and Smad1 Mediate Extracellular Matrix Production in the Development of Diabetic Nephropathy.
    Matsubara T; Araki M; Abe H; Ueda O; Jishage K; Mima A; Goto C; Tominaga T; Kinosaki M; Kishi S; Nagai K; Iehara N; Fukushima N; Kita T; Arai H; Doi T
    Diabetes; 2015 Aug; 64(8):2978-90. PubMed ID: 25995358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circ-AKT3 inhibits the accumulation of extracellular matrix of mesangial cells in diabetic nephropathy via modulating miR-296-3p/E-cadherin signals.
    Tang B; Li W; Ji TT; Li XY; Qu X; Feng L; Bai S
    J Cell Mol Med; 2020 Aug; 24(15):8779-8788. PubMed ID: 32597022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of mesangial cells to low-density lipoprotein and angiotensin II in diabetic (OLETF) rats.
    Okada M; Takemura T; Yanagida H; Yoshioka K
    Kidney Int; 2002 Jan; 61(1):113-24. PubMed ID: 11786091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liraglutide suppresses production of extracellular matrix proteins and ameliorates renal injury of diabetic nephropathy by enhancing Wnt/β-catenin signaling.
    Huang L; Lin T; Shi M; Chen X; Wu P
    Am J Physiol Renal Physiol; 2020 Sep; 319(3):F458-F468. PubMed ID: 32715762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
    Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells.
    Subathra M; Korrapati M; Howell LA; Arthur JM; Shayman JA; Schnellmann RG; Siskind LJ
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F204-15. PubMed ID: 26041445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of integrin subunits in human diabetic kidneys.
    Jin DK; Fish AJ; Wayner EA; Mauer M; Setty S; Tsilibary E; Kim Y
    J Am Soc Nephrol; 1996 Dec; 7(12):2636-45. PubMed ID: 8989742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative investigation of kidney mesangial cells from increased oxidative stress-induced diabetic rats by using different microscopy techniques.
    Sargin AK; Can B; Turan B
    Mol Cell Biochem; 2014 May; 390(1-2):41-9. PubMed ID: 24374793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy.
    Jha JC; Banal C; Okabe J; Gray SP; Hettige T; Chow BSM; Thallas-Bonke V; De Vos L; Holterman CE; Coughlan MT; Power DA; Skene A; Ekinci EI; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm K
    Diabetes; 2017 Oct; 66(10):2691-2703. PubMed ID: 28747378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of megsin siRNA plasmid reveals therapeutic potential against diabetic nephropathy by down-regulating p27(kip1) level.
    Liu M; Zhang Y; Chi Y; Zhai S; Wang B; Shi Y; Li Y
    J Nephrol; 2012; 25(3):418-25. PubMed ID: 21928229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The current clinical problems for early phase of diabetic nephropathy and approach for pathogenesis of diabetic nephropathy.
    Doi T; Mima A; Matsubara T; Tominaga T; Arai H; Abe H
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S21-4. PubMed ID: 18842318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the Mechanisms Involved in the Expression and Regulation of Extracellular Matrix Proteins in Diabetic Nephropathy.
    Hu C; Sun L; Xiao L; Han Y; Fu X; Xiong X; Xu X; Liu Y; Yang S; Liu F; Kanwar YS
    Curr Med Chem; 2015; 22(24):2858-70. PubMed ID: 26119175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.